Computational modelling of LY303511 and TRAIL-induced apoptosis suggests dynamic regulation of cFLIP

Bioinformatics

Volumn 29, Issue 3, 2013, Pages 347-354

  Shi, Yuan ^a   Mellier, Gregory ^b   Huang, Sinong ^c   White, Jacob ^d   Pervaiz, Shazib ^a,b,c,e   Tucker Kellogg, Lisa ^a,f,g  

^a SINGAPORE MIT ALLIANCE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d Department of Electrical Engineering and Computer Science   (United States)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CHROMONE DERIVATIVE; FLICE INHIBITORY PROTEIN; LY 303511; PIPERAZINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; COMPUTER SIMULATION; DRUG POTENTIATION; HELA CELL; HUMAN; METABOLISM;

APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CHROMONES; COMPUTER SIMULATION; DRUG SYNERGISM; HELA CELLS; HUMANS; PIPERAZINES; REACTIVE OXYGEN SPECIES; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

MLCS; MLOWN;

EID: 84873310361     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/bts702     Document Type: Article

References (55)

1. Abdulghani, J. and El-Deiry, W.S. (2010) TRAIL receptor signaling and therapeutics. Expert Opin. Ther. Targets, 14, 1091-1108.
2. Akram, S. et al. (2006) Reactive oxygen species-mediated regulation of the Na\+-H\+ exchanger 1 gene expression connects intracellular redox status with cells' sensitivity to death triggers. Cell Death Differ., 13, 628-641.
3. Albeck, J.G. et al. (2008a) Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol. cell, 30, 11-25. (Pubitemid 351470145)
4. Albeck, J.G. et al. (2008b) Modeling a snap-action, variable-delay switch controlling extrinsic cell death. PLoS Biol., 6, 2831-2852.
5. Amm, H.M. et al. (2011) Combined modality therapy with TRAIL or agonistic death receptor antibodies. Cancer Biol. Ther., 11, 431-449.
6. Bagci, E.Z. et al. (2006) Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. Biophys. J., 90, 1546-1559.
7. Brennan, M.D. et al. (2012) Systems biology. How information theory handles cell signaling and uncertainty. Science, 338, 334-335.
8. Chait, R. et al. (2007) Antibiotic interactions that select against resistance. Nature, 446, 668-671. (Pubitemid 46606886)
9. Clément, M.V. and Pervaiz, S. (2001) Intracellular superoxide and hydrogen peroxide concentrations: a critical balance that determines survival or death. Redox Rep., 6, 211-214. (Pubitemid 32962820)
10. Davies, S.P. et al. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J., 351, 95-105.
11. Ding, L. et al. (2011) Cisplatin restores TRAIL apoptotic pathway in glioblastomaderived stem cells through up-regulation of DR5 and down-regulation of c-FLIP. Cancer Invest., 29, 511-520.
12. Eissing, T. et al. (2004) Bistability analyses of a caspase activation model for receptor-induced apoptosis. J. Biol. Chem., 279, 36892-36897. (Pubitemid 39129038)
13. Falschlehner, C. et al. (2007) TRAIL signalling: decisions between life and death. Int. J. Biochem. Cell Biol., 39, 1462-1475. (Pubitemid 47031030)
14. Ferreira, K.S. et al. (2012) Caspase-3 feeds back on caspase-8, Bid and XIAP in type I Fas signaling in primary mouse hepatocytes. Apoptosis, 17, 503-515.
15. Fitzgerald, J.B. et al. (2006) Systems biology and combination therapy in the quest for clinical efficacy. Nat. Chem. Biol., 2, 458-466. (Pubitemid 44266307)
16. Fukazawa, T. et al. (2001) Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene, 20, 5225-5231. (Pubitemid 32844053)
17. Geserick, P. et al. (2008) Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL-and CD95L-mediated apoptosis. Oncogene, 27, 3211-3220. (Pubitemid 351693178)
18. Gharbi, S.I. et al. (2007) Exploring the specificity of the PI3K family inhibitor LY294002. Biochem. J., 404, 15-21. (Pubitemid 46788080)
19. Hampton, M.B. and Orrenius, S. (1997) Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett., 414, 552-556. (Pubitemid 27390666)
20. Heikaus, S. et al. (2008) Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARC. Apoptosis, 13, 938-949.
21. Hietakangas, V. et al. (2003) Erythroid differentiation sensitizes K562 leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP. Mol. Cell Biol., 23, 1278-1291. (Pubitemid 36177037)
22. Hoops, S. et al. (2006) COPASI-a complex pathway simulator. Bioinformatics, 22, 3067-3074.
23. Hua, F. et al. (2005) Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. J. Immunol., 175, 985-995. (Pubitemid 41094983)
24. Ivanov, V.N. et al. (2008) Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. Exp. Cell Res., 314, 1163-1176.
25. Iyer, A.K. et al. (2008) Role of S-nitrosylation in apoptosis resistance and carcinogenesis. Nitric Oxide, 19, 146-151.
26. Jacobs, M.D. et al. (2005) Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002. J. Biol. Chem., 280, 13728-13734. (Pubitemid 40517268)
27. Jo, D.G. et al. (2004) Calcium binding of ARC mediates regulation of caspase 8 and cell death. Mol. Cell Biol., 24, 9763-9770.
28. Juan, M.E. et al. (2008) Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells. J. Agric. Food Chem., 56, 4813-4818. (Pubitemid 351999415)
29. Kim, Y.H. et al. (2008) Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen speciesmediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic. Biol. Med., 44, 1055-1068.
30. Koch, G. et al. (2009)Modeling of tumor growth and anticancer effects of combination therapy. J. Pharmacokinet. Pharmacodyn., 36, 179-197.
31. Kreuz, S. et al. (2001) NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol., 21, 3964-3973. (Pubitemid 32476458)
32. Kristof, A.S. et al. (2005) LY303511 (2-piperazinyl-8-phenyl-4H-1- benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)-and non-mTOR-dependent mechanisms. J. Pharmacol. Exp. Ther., 314, 1134-1143. (Pubitemid 41205978)
33. Krueger, A. et al. (2001) Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem., 276, 20633-20640.
34. Lee, J.Y. et al. (2007) The NO TRAIL to YES TRAIL in cancer therapy (review). Int. J. Oncol., 31, 685-691.
35. Lee, T.J. et al. (2009) Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and downregulation of c-FLIP. Free Radic. Biol. Med., 46, 1639-1649.
36. Lim, S. and Clement, M.V. (2007) Phosphorylation of the survival kinase Akt by superoxide is dependent on an ascorbate-reversible oxidation of PTEN. Free Radic. Biol. Med., 42, 1178-1192. (Pubitemid 46428511)
37. Nitobe, J. et al. (2003) Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. Cardiovasc. Res., 57, 119-128. (Pubitemid 36009443)
38. Pervaiz, S. and Clément, M.V. (2002) A permissive apoptotic environment: function of a decrease in intracellular superoxide anion and cytosolic acidification. Biochem. Biophys. Res. Commun., 290, 1145-1150. (Pubitemid 34694425)
39. Pervaiz, S. and Clement, M.V. (2007) Superoxide anion: oncogenic reactive oxygen species? Int. J. Biochem. Cell boil., 39, 1297-1304. (Pubitemid 47031046)
40. Peter, M.E. (2004) The flip side of FLIP. Biochem. J., 382, e1-e3.
41. Poh, T.W. and Pervaiz, S. (2005) LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway. Cancer Res., 65, 6264-6274. (Pubitemid 40994412)
42. Poh, T.W. et al. (2007) LY303511 amplifies TRAIL-induced apoptosis in tumor cells by enhancing DR5 oligomerization, DISC assembly, and mitochondrial permeabilization. Cell Death Differ., 14, 1813-1825. (Pubitemid 47423648)
43. Polking, J.C. (1995) MATLAB Manual for Ordinary Differential Equations. Prentice-Hall, Englewood Clis, NJ.
44. Ruffels, J. et al. (2004) Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: role of ERK1/2 in H2O2induced cell death. Eur. J. Pharmacol., 483, 163-173. (Pubitemid 38068397)
45. Shenoy, K. et al. (2009) LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors. Cancer Res., 69, 1941-1950.
46. Smieja, J. et al. (2008) Model-based analysis of interferon-beta induced signaling pathway. Bioinformatics, 24, 2363-2369.
47. Tang, H. et al. (2011) The scavenging of superoxide radicals promotes apoptosis induced by a novel cell-permeable fusion protein, sTRAIL:FeSOD, in tumor necrosis factor-related apoptosis-inducing ligand-resistant leukemia cells. BMC Biol., 9, 18.
48. Toettcher, J. et al. (2010) Recycling circuit simulation techniques for mass-action biochemical kinetics. In: Peng, L. (ed.) Simulation and Verification of Electronic and Biological Systems. Springer, Heidelberg, Germany.
49. Wang, S. (2008) The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway. Oncogene, 27, 6207-6215.
50. Yamakawa, H. et al. (2000) Activation of caspase-9 and-3 during H2O2-induced apoptosis of PC12 cells independent of ceramide formation. Neurol. Res., 22, 556-564.
51. Yang, S. et al. (2006) Caspase-3 mediated feedback activation of apical caspases in doxorubicin and TNF-alpha induced apoptosis. Apoptosis, 11, 1987-1997. (Pubitemid 44691582)
52. Zhang, L. and Fang, B. (2005) Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther., 12, 228-237. (Pubitemid 40315182)
53. Zhu, P. et al. (2011) Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell, 19, 401-415.
54. Zou, H. et al. (2003) Regulation of the Apaf-1/caspase-9 apoptosome by caspase-3 and XIAP. J. Biol. Chem., 278, 8091-8098. (Pubitemid 36800549)
55. Zuo, Y. et al. (2009) Oxidative modification of caspase-9 facilitates its activation via disulfide-mediated interaction with Apaf-1. Cell Res., 19, 449-457.